Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 16/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 14/20 | 0.78 |
| ▸ | DRD2 | P14416 | 1/20 | 0.64 |
| ▸ | DRD1 | P21728 | 1/20 | 0.64 |
| ▸ | DRD4 | P21917 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8808167 | 0.89 | ABCG2 (0.88) | ABCG2ABCB1DRD2DRD1DRD4 | |
| SCHEMBL8808324 | 0.88 | ABCB1 (0.65) | ABCG2ABCB1MAOAMAOB | |
| SCHEMBL8812802 | 0.88 | ABCG2 (1.00) | ABCG2ABCB1 | |
| SCHEMBL8807711 | 0.84 | ABCB1 (0.59) | ABCG2ABCB1MAOAMAOB | |
| SCHEMBL8807296 | 0.83 | ABCG2 (0.79) | ABCG2ABCB1MAOAMAOBCYP1A2 | |
| SCHEMBL14722808 | 0.83 | DRD3 (0.90) | ABCG2ABCB1DRD2DRD1DRD4 | |
| SCHEMBL8809580 | 0.82 | ABCB1 (0.59) | ABCG2ABCB1DRD1DRD4DRD3 | |
| SCHEMBL8809233 | 0.81 | ABCG2 (0.78) | ABCG2ABCB1MAOBCYP1A2CYP2C8 | |
| SCHEMBL8809520 | 0.80 | ABCB1 (0.55) | ABCG2ABCB1MAOAMAOB | |
| SCHEMBL4040694 | 0.80 | ABCB1 (0.77) | ABCG2ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663179-A | CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS | LABORATOIRES GLAXO SA (FR) | 1997-09-02 | — | — | US | disclosed |
| EP-0649410-B1 | ANILIDE DERIVATIVES | GLAXO LAB SA (FR) | 1997-05-02 | — | — | EP | disclosed |